We are live on ! Find out more
ARQT icon

Arcutis Biotherapeutics
ARQT

56 hedge funds and large institutions have $1.02B invested in Arcutis Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

12% more funds holding

Funds holding: 50 → 56 (+6)

2.7% more ownership

Funds ownership: 85.82% → 88.51% (+2.7%)

5% more capital invested

Capital invested by funds: $974M → $1.02B (+$47.3M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
11
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.3M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.84M
3
Wells Fargo
Wells Fargo
California
+$3.28M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.66M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.48M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$11.5M
2
MWNA
Marshall Wace North America
New York
-$1.23M
3
Goldman Sachs
Goldman Sachs
New York
-$801K
4
CCM
CAAS Capital Management
New York
-$668K
5
Citadel Advisors
Citadel Advisors
Florida
-$650K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$784K +$406K +14,055 +118%
Swiss National Bank
27
Swiss National Bank
Switzerland
$644K +$616K +21,300 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$635K +$607K +20,996 New
Stifel Financial
29
Stifel Financial
Missouri
$630K +$25.8K +891 +4%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$619K – – –
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$484K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$432K -$43.9K -1,520 -10%
VEA
33
Virtus ETF Advisers
New York
$415K +$396K +13,718 New
Squarepoint
34
Squarepoint
New York
$376K +$359K +12,422 New
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$351K +$335K +11,592 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$334K +$33.2K +1,150 +12%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$289K +$276K +9,546 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$284K +$272K +9,400 New
SG Americas Securities
39
SG Americas Securities
New York
$246K +$129K +4,456 +121%
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$227K – – –
AIG
41
American International Group
New York
$175K -$10.5K -362 -6%
MIM
42
MetLife Investment Management
New Jersey
$162K – – –
Deutsche Bank
43
Deutsche Bank
Germany
$143K +$30.8K +1,067 +29%
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$114K – – –
Bank of America
45
Bank of America
North Carolina
$114K -$25.9K -896 -19%
Morgan Stanley
46
Morgan Stanley
New York
$108K +$61.7K +2,136 +149%
JP Morgan Chase
47
JP Morgan Chase
New York
$96K -$4.39K -152 -5%
UBS Group
48
UBS Group
Switzerland
$94K -$97K -3,358 -52%
Citigroup
49
Citigroup
New York
$91K -$87 -3 -0.1%
Legal & General Group
50
Legal & General Group
United Kingdom
$48K -$1.33K -46 -3%
1
2
3

ARQT Hedge Fund Activity: Q2 2020 in Review

56 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Arcutis Biotherapeutics (ARQT) for Q2 2020, worth a combined $1.02B — up 4.9% from $974M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ARQT positions and 5 closed out — a net gain of 6 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $20.3M. The largest seller was Vivo Capital, cutting an estimated $11.5M.

  • 56 institutional investors held Arcutis Biotherapeutics (ARQT) as of Q2 2020, up from 50 in Q1 2020.
  • Funds reported $1.02B of Arcutis Biotherapeutics stock for Q2 2020, up 4.9% quarter-over-quarter.
  • 11 funds opened new Arcutis Biotherapeutics positions in Q2 2020 and 5 closed out, a net change of +6 holders.
  • The largest Arcutis Biotherapeutics buyer in Q2 2020 was BlackRock, an estimated $20.3M added.
  • The largest Arcutis Biotherapeutics seller in Q2 2020 was Vivo Capital, an estimated $11.5M sold.

Based on aggregated 13F filings for Q2 2020.